This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Locally Advanced Malignant Neoplasm or Rectal Carcinoma
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine whether the tailored management of locally advanced rectal carcinoma can improve the oncologic and functional outcome.

Provided treatments

  • Drug: Induction trichemotherapy - FOLFIRINOX regimen
  • Other: Early tumor response evaluation by MRI volumetry
  • Radiation: Radiochemotherapy Cap 50
  • Radiation: Radiochemotherapy Cap 60
  • Procedure: Radical proctectomy with total mesorectal excision

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01333709. The sponsor of the trial is Institut du Cancer de Montpellier - Val d'Aurelle and it is looking for 150 volunteers for the current phase.
Official trial title:
A Randomized Multicenter Phase 2 Study: a Tailored Strategy for Locally Advanced Rectal Carcinoma